Comparing written exposure therapy to Prolonged Exposure for the treatment of PTSD in a veteran sample: A non-inferiority randomized design

被引:12
作者
Sloan, Denise M. [1 ,2 ]
Marx, Brian P. [1 ,2 ]
Acierno, Ronald [3 ]
Messina, Michael [4 ]
Cole, Travis A. [1 ]
机构
[1] Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA USA
[2] Boston Univ, Sch Med, Boston, MA 02118 USA
[3] Univ Texas Hlth Sci Ctr Houston, Faillace Dept Psychiat, Houston, TX 77030 USA
[4] William S Middleton VA Med Ctr, Madison, WI USA
关键词
Clinical trial; Posttraumatic stress disorder; Exposure-based treatment; Military veterans; Trauma-focused treatment; POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE PROCESSING THERAPY; IMAGINAL EXPOSURE; PSYCHOTHERAPY; TELEMEDICINE; METAANALYSIS; DEPRESSION; EFFICACY; WOMEN; TRIAL;
D O I
10.1016/j.conctc.2021.100764
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Posttraumatic stress disorder (PTSD) is highly prevalent among veterans. Although there are effective treatment approaches for PTSD, such as Prolonged Exposure (PE) and Cognitive Processing Therapy, many providers trained in these approaches do not use them, or use them without sufficient fidelity, and veterans drop out of these treatments at very high rates. The time intensive nature of these treatments is frequently cited as a barrier to receiving the treatment among veterans and delivering the treatment among providers. According, there is an urgent need to establish more efficient and effective PTSD treatment approaches in order to meet the needs of veterans seeking care. Written exposure therapy (WET) is an efficient, exposure-based treatment, and may represent a plausible alternative treatment option to address PTSD in veterans. Although WET has been found to be effective and non-inferior to more time intensive trauma-focused treatment, it has not yet been investigated with a veteran sample. In an ongoing randomized controlled trial (RCT) we are investigating whether WET is non-inferior in treating PTSD compared with the more time intensive PE. The study sample will include 150 men and women veterans diagnosed with PTSD who are randomly assigned to either WET (n = 75) or PE (n = 75). Participants are assessed prior to treatment and 10-, 20-, and 30-weeks after the first treatment session. The primary outcome is PTSD symptom severity assessed with the Clinician Administered PTSD Scale for DSM-5. Establishing that PTSD can be treated effectively with fewer treatment sessions would represent a significant advance in improving access to evidence-based care for veterans with PTSD.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Comparing the unified protocol for transdiagnostic treatment of emotional disorders to prolonged exposure for the treatment of PTSD: Design of a non-inferiority randomized controlled trial
    Lau, W.
    Chisholm, K.
    Gallagher, M. W.
    Felmingham, K.
    Murray, K.
    Pearce, A.
    Doyle, N.
    Alexander, S.
    O'Brien, H.
    Putica, A.
    Khatri, J.
    Bockelmann, P.
    Hosseiny, F.
    Librado, A.
    Notarianni, M.
    O'Donnell, M. L.
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2023, 33
  • [2] A randomized clinical trial comparing Interpersonal Psychotherapy with Prolonged Exposure for the treatment of PTSD in veterans
    Shea, M. Tracie
    Krupnick, Janice L.
    Sautter, Frederic J.
    Mete, Mihriye
    Green, Bonnie L.
    Norman, Sonya B.
    Finley, Shauna L.
    Eaton, Erica
    JOURNAL OF ANXIETY DISORDERS, 2023, 99
  • [3] Written exposure therapy for veterans with co-occurring substance use disorders and PTSD: Study design of a randomized clinical trial
    Meshberg-Cohen, Sarah
    Cook, Joan M.
    Bin-Mahfouz, Amirah
    Petrakis, Ismene L.
    CONTEMPORARY CLINICAL TRIALS, 2024, 139
  • [4] Trauma Management Therapy and Prolonged Exposure Therapy for PTSD in an active duty sample: Design and methodology of a randomized clinical trial
    Beidel, Deborah C.
    Neer, Sandra M.
    Bowers, Clint A.
    Newins, Amie R.
    Tuerk, Peter W.
    Cunningham, Craig A.
    Mooney, Scott R.
    Hauck, Heather N.
    Jett, Marti
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2020, 17
  • [5] An Overview of Written Exposure Therapy: A Brief Treatment for PTSD
    Sloan, Denise M.
    Marx, Brian P.
    PSYCHIATRIC ANNALS, 2024, 54 (03) : e70 - e74
  • [6] Prolonged Exposure Therapy for a Vietnam Veteran With PTSD and Early-Stage Dementia
    Duax, Jeanne M.
    Waldron-Perrine, Brigid
    Rauch, Sheila A. M.
    Adams, Kenneth M.
    COGNITIVE AND BEHAVIORAL PRACTICE, 2013, 20 (01) : 64 - 73
  • [7] Enhancing prolonged exposure therapy for PTSD among veterans with oxytocin: Design of a multisite randomized controlled trial
    Flanagan, Julianne C.
    Mitchell, Jennifer M.
    Baker, Nathaniel L.
    Woolley, Joshua
    Wangelin, Bethany
    Back, Sudie E.
    McQuaid, John R.
    Neylan, Thomas C.
    Wolfe, William R.
    Brady, Kathleen T.
    CONTEMPORARY CLINICAL TRIALS, 2020, 95
  • [8] Study design comparing written exposure therapy to cognitive processing therapy for PTSD among military service members: A noninferiority trial
    Sloan, Denise M.
    Marx, Brian P.
    Resick, Patricia A.
    Young-McCaughan, Stacey
    Dondanville, Katherine A.
    Mintz, Jim
    Litz, Brett T.
    Peterson, Alan L.
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2020, 17
  • [9] Doubly Randomized Preference Trial of Prolonged Exposure Versus Sertraline for Treatment of PTSD
    Zoellner, Lori A.
    Roy-Byrne, Peter P.
    Mavissakalian, Matig
    Feeny, Norah C.
    AMERICAN JOURNAL OF PSYCHIATRY, 2019, 176 (04) : 287 - 296
  • [10] Effect of massed v. standard prolonged exposure therapy on PTSD in military personnel and veterans: a non-inferiority randomised controlled trial
    Dell, Lisa
    Sbisa, Alyssa M.
    Forbes, Andrew
    O'Donnell, Meaghan
    Bryant, Richard
    Hodson, Stephanie
    Morton, David
    Battersby, Malcolm
    Tuerk, Peter W.
    Wallace, Duncan
    Forbes, David
    PSYCHOLOGICAL MEDICINE, 2023, 53 (09) : 4192 - 4199